Institute for Cell, Gene, and Immunotherapy
Speeding translation of innovation to clinical care
Accelerating the development and testing of novel cell, gene and immune-based therapeutics that hold promise in the treatment of life-threatening diseases.
Connecting Clinical Research to Industry and Community
The institute will build on existing strengths at the University, further develop high-tech core capabilities, and connect to industry partners with access to new technologies in order to speed translation of innovation to clinical care. Read about our Core Services.
John Wagner, MD has been a key contributor to establishing the University’s international leadership in stem cell and umbilical cord blood transplantation. He is a professor of pediatrics, Co-Director of the Center for Translational Medicine, Program Co-Leader of Transplant Biology and Therapy within the Masonic Cancer Center and Director of the Pediatric Blood and Marrow Transplant Program from 2004 to July 2019.